, Singapore

Share buybacks reached $39.3m for the 2nd week of March

Check out the five stocks with the largest consideration.

For the second week of the month from 9 to 13 March, there were a total of 43,923,800 shares repurchased by 21 stocks with a total consideration of S$53.8 million.

According to SGX, this was an increase from the second week of March last year, which saw a total of 6,484,000 shares purchased by 12 stocks with a total consideration of S$39.3 million.

In the month to date, there were a total of 60,545,700 shares repurchased by 26 stocks with a total consideration of S$78.9 million. This is up from S$45.9 million in consideration for the first two weeks of March last year.

The five stocks with the largest consideration amount in buybacks last week were Genting Singapore PLC, Singapore Technologies Engineering, Oversea-Chinese Banking Corporation, Wing Tai Holdings, and Indofood Agri Resources. 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

AI growth stalls as 78% cite weak data infrastructure
Confluent said firms are prioritising data streaming as they move AI projects from pilots into production.
Singapore emerges as key hub in Asia-Pacific’s next medtech wave
The city-state’s regulatory strength helps translate medical innovations into globally validated products.
Healthcare